Rationale for a conditional knockout mouse model to study carnitine palmitoyltransferase I deficiencies

Advances in Experimental Medicine and Biology

Volumn 466, Issue , 2000, Pages 377-385

  Van der Leij, F R ^a   Drijfholt, A ^a   Kuipers, J R G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE;

CARDIOMYOPATHY; CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY; CONFERENCE PAPER; ENZYME DEFICIENCY; GENE DISRUPTION; GENE INACTIVATION; GENETIC DISORDER; KNOCKOUT GENE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CARDIOMYOPATHIES; CARNITINE O-PALMITOYLTRANSFERASE; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, KNOCKOUT; RATS;

MURINAE;

EID: 0034468924     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (44)

1. Myocardial utilization of carbohydrate and lipids
2. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis
3. Mitochondrial carnitine palmitoyltransferase I isoform switching in the developing rat heart
4. Human liver mitochondrial carnitine palmitoyltransferase I: Characterization of its cDNA and chromosomal localization and partial analysis of the gene
5. Fine chromosome mapping of the genes for human liver and muscle carnitine palmitoyltransferase I (CPT1A and CPT1B)
6. Localization and intron usage analysis of the human CPT1B gene for muscle type carnitine palmitoyltransferase I
7. Molecular basis of mitochondrial fatty acid oxidation defects
8. Inherited cardiomyopathies
9. Clinical approach to genetic cardiomyopathy in children
10. Carnitine-acylcarnitine translocase deficiency - A mild phenotype
11. Muscle carnitine palmityltransferase deficiency and myoglobinuria
12. Brief report: A deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane
13. Carnitine-acylcarnitine translocase deficiency with severe hypoglycemia and auriculo ventricular block. Translocase assay in permeabilized fibroblasts
14. A patient with lethal cardiomyopathy and a carnitine-acylcarnitine translocase deficiency
15. Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies
16. Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II
17. Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency
18. Hepatic and muscular presentations of carnitine palmitoyl transferase deficiency: Two distinct entities
19. Atypical features of the hepatic form of carnitine palmitoyltransferase deficiency in a Hutterite family
20. Rate-dependent distal renal tubular acidosis and carnitine palmitoyltransferase I deficiency
21. Characterisation of carnitine palmitoyltransferases in patients with a carnitine palmitoyltransferase deficiency: Implications for diagnosis and therapy
22. Normal muscle CPT1 and CPT2 activities in hepatic presentation patients with CPT1 deficiency in fibroblasts. Tissue specific isoforms of CPT1?
23. Comparison of the effects of carnitine palmitoyltransferase-1 and -2 inhibitors on rat heart hypertrophy
24. Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor
25. Mouse white adipocytes and 3T3-L1 cells display an anomalous pattern of carnitine palmitoyltransferase (CPT) I isoform expression during differentiation. Inter-tissue and inter-species expression of CPT I and CPT II enzymes
26. Genetically haploid spermatids are phenotypically diploid
27. Cytogenetic, biochemical, and molecular analyses of a 22q13 deletion
28. Clinical, cytogenetic, and molecular characterization of seven patients with deletions of chromosome 22q13.3
29. Cryptic terminal rearrangement of chromosome 22q13.32 detected by FISH in two unrelated patients
30. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat
31. High frequency targeting of genes to specific sites in the mammalian genome
32. Cardiac physiology in transgenic mice
33. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1
34. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting
35. Knockout mice: Round two
36. A cre-transgenic mouse strain for the ubiquitous deletion of loxP- flanked gene segments including deletion in germ cells
37. Ventricular muscle-restricted targeting of the RXR(alpha) gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis
38. Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene
39. Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo
40. Structural features of the gene encoding human muscle type carnitine palmitoyltransferase I
41. Genomic DNA sequence, promoter expression, and chromosomal mapping of rat muscle carnitine palmitoyltransferase I
42. Cloning and characterization of the promoter for the liver isoform of the rat carnitine palmitoyltransferase I (L-CPT I) gene
43. Green fluorescent protein as a marker for gene expression